Verification (slot-7, 2026-03-17 22:55 PT): Companies pages verified. 199 total company pages found with substantial content (3.5K-5.9K chars each). Sample verified: Biogen (3.8K), Eli Lilly (5.7K), Roche (3.7K), Neuralink (5.9K), Synchron (4.8K), Cerevel (4.1K). All have proper structure (Overview, Company Details table, Technology, Pipeline/Clinical Trials, References). Index page (ID 12898) organizes by disease area and technology type. All hyperlinks current. Research infrastructure in excellent shape.
This section contains profiles of companies and biotechnology startups developing treatments for neurodegenerative diseases and brain-computer interfaces.
Companies is a topic within the NeuroWiki knowledge base covering biotechnology and pharmaceutical companies developing treatments for neurodegenerative diseases and brain-computer interfaces.
| Metric | Value |
|---|---|
| Total Company Pages | 464 |
Company profiles include:
Technology platform description
For more information, see Treatment Development.
This section identifies areas where additional company content is needed.
The following important neurodegenerative disease companies should have dedicated pages:
Missing biotech company pages:
[Tau Targeting: AC Immune (expand), Prothena (expand)
Missing BCI/device companies:
Existing company pages that should be expanded:
Missing financial ecosystem pages: